Featured
ICD Ultra-Rare Framework Comment
ICD Ultra-Rare Framework Comment
Haystack MA Part D comment 1.26.26
Haystack MA Part D comment 1.26.26
Haystack IPPS Comment 6.10.25
Haystack IPPS Comment 6.10.25
Haystack 6.10.24 IPPS Comment
Haystack 6.10.24 IPPS Comment
Haystack MA RFI Response 5.29.24
Haystack MA RFI Response 5.29.24
Haystack MPPP Model Documents Comment
Haystack MPPP Model Documents Comment
RFI on Improving and Protecting Access to Gene Therapies
RFI on Improving and Protecting Access to Gene Therapies
Medicare Prescription Payment Plan Guidance
Medicare Prescription Payment Plan Guidance
Haystack Comments on CMS Proposed Evidence Standards NCD
Haystack Comments on CMS Proposed Evidence Standards NCD
Haystack Comments CMS Proposal on CED
Haystack Comments CMS Proposal on CED
Haystack's Comments on Craft of bill on State Integrated Care Programs for Dual Eligible Individuals
Haystack's Comments on Craft of bill on State Integrated Care Programs for Dual Eligible Individuals
Haystack's comments on CMS’ proposed rule on the Medicaid and Children’s Health Insurance Program (CHIP)
Haystack's comments on CMS’ proposed rule on the Medicaid and Children’s Health Insurance Program (CHIP)
Haystack comments on CMS' proposed rule to update IPPS
Haystack comments on CMS' proposed rule to update IPPS
Haystack IRA data elements ICR 5.22.23
Haystack IRA data elements ICR 5.22.23
Haystack's comments in response to CMS' Notice of proposed rulemaking on Advancing Interoperability & Improving Prior Authorization Processes
Haystack's comments in response to CMS' Notice of proposed rulemaking on Advancing Interoperability & Improving Prior Authorization Processes
Haystack's Comments in response to CMS' Medicare Part B Inflation Rebate Guidance
Haystack's Comments in response to CMS' Medicare Part B Inflation Rebate Guidance
Haystack's comments in response to CMS' Medicare Part D Inflation Rebate Guidance
Haystack's comments in response to CMS' Medicare Part D Inflation Rebate Guidance
Haystack's Comments on CMS Proposal to Oppose For Rare Diseases
Haystack's Comments on CMS Proposal to Oppose For Rare Diseases
Haystack's comments on CMS' RFI related to EHB under the ACA
Haystack's comments on CMS' RFI related to EHB under the ACA
Haystack's sign-on letter providing analysis of coverage with evidence development (CED) criteria
Haystack's sign-on letter providing analysis of coverage with evidence development (CED) criteria
Haystack's comments on improving coverage for individuals dully-eligible for Medicare and Medicaid
Haystack's comments on improving coverage for individuals dully-eligible for Medicare and Medicaid
Haystack Responds to CMS’ National Provider Directory RFI
Haystack Responds to CMS’ National Provider Directory RFI
Finance Democrats Call for More Consumer Protections in Medicare Advantage
Finance Democrats Call for More Consumer Protections in Medicare Advantage
Haystack Response to CMS' Make Your Voice Heard RFI
Haystack Response to CMS' Make Your Voice Heard RFI
Haystack signs on to Telehealth Stakeholder Letter to Senate
Haystack signs on to Telehealth Stakeholder Letter to Senate
Haystack Project highlights the need for well-meaning proposals to consider impact on rare patients.
Haystack Project highlights the need for well-meaning proposals to consider impact on rare patients.
Haystack Responds to HHS RFI on Improving Primary Care
Haystack Responds to HHS RFI on Improving Primary Care
Haystack Project's reply to CMS' Hospital Inpatient Prospective Payment Systems
Haystack Project's reply to CMS' Hospital Inpatient Prospective Payment Systems
Haystack Project's sign-on letter commenting to CMS' proposed NCA for monoclonal antibodies
Haystack Project's sign-on letter commenting to CMS' proposed NCA for monoclonal antibodies
Haystack Project Applauds Introduction of the Access to Rare Indications Act
Haystack Project Applauds Introduction of the Access to Rare Indications Act